The below lectures have been confirmed until now at ESSDD-6. The list will be updated soon.

  1. Abu Serajuddin, St. John’s University, USA
    Biophamaceutical Risk Assessment Roadmap (BioRAM): Optimization of Clinical Drug Product Performance
  2. Kiyohiko Sugano, Ritsumeikan University, Japan
    Basics of Modeling and Simulation in Biopharmaceutics
  3. Klara Valko, Bio-mimetic chromatography Ltd. UK
    Application of Lipophilicity, Protein and Phospholipid Binding Measured by HPLC for Prediction of ADME Properties and Toxicity of Compounds
  4. Alex Avdeef, in-ADME Reserch, USA
    Salt Solubility - New Insights from ‘Purposeful Loitering’
  5. Gaia Colombo, University of Ferrara, Italy
    Tuning Technologies for Intranasal Drug Delivery Unravel the Multiplicity of Achievable Therapeutic Targets via the Nose
  6. Tatjana Verbić, University of Belgrade, Serbia
    Measurements of Plasma Protein Binding – Variety of Experimental Techniques
  7. Katarina Nikolić, University of Belgrade, Serbia
    Computer-aided Design of Multitarget Ligands
  8. Godefridus Peters, VU University Medical Center, The Netherlands
    Drug Development in Cancer
  9. Rolf Hilfiker, Solvias AG, Switzerland
    The Importance of Choosing Optimal Solid Form of a Drug: Salts, Co-crystals, Polymorphs, Amorphous, Solvates
  10. Christel Bergström, Uppsala University, Sweden
    Solubility, Permeability and Formulation Studies in Early Drug Development